Merck & Co., Inc. is pushing for a fast court decision in a lawsuit it earlier filed against the US government over the implementation of a new Medicare drug price negotiation program, authorized by the Inflation Reduction Act (IRA). With just weeks to go until the US Centers for Medicare & Medicaid Services reaches key deadlines for the implementation of the program, Merck, in an 11 July court filing, urged a district court to make a summary judgement in the case.
Merck was the first plaintiff to file a lawsuit against the IRA, with legal action taken in Washington, DC, district court on 6 June. (Also see "Merck Files First IRA Suit, Signaling Industry Is Ready To Fight" - Pink Sheet, 7 June, 2023.) Other lawsuits have followed since, including one by the US Chamber of Commerce and one by the Pharmaceutical Research and Manufacturers of America (PhRMA)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?